BioSpace News Archive

Drug Development

AEterna Zentaris Announces Completion Of Patient Enrollment For Ozarelix Phase II Trial In Benign Prostatic Hyperplasia

November 21, 2005
·
1 min read
Business

PainCare Holdings, Inc. Appoints Beemer, Pricher, Kuehnhackl & Heidbrink, P.A. As New Auditing Firm

November 21, 2005
·
5 min read
AtheroGenics To Present At Lazard Capital Markets Annual Life Sciences Conference On November 29, 2005

November 21, 2005
·
1 min read
Policy

FDA Grants Priority Review To Cubist Pharmaceuticals, Inc. Antibiotic CUBICIN

November 21, 2005
·
1 min read
Business

AEterna Zentaris Appoints A Board Vice Chairman, A New Chair Of The Corporate Governance Committee, Two New Scientific Advisory Board Members And An IR Director

November 21, 2005
·
6 min read
Drug Development

AEterna Zentaris Announces Completion Of Patient Enrollment For Ozarelix (D-63153) Phase II Trial In Benign Prostatic Hyperplasia

November 21, 2005
·
4 min read
FDA

Par Pharmaceutical Companies, Inc. Receives Approval And Marketing Exclusivity For Ondanestron Hydrochloride Orally Disintegrating Tablets

November 21, 2005
·
2 min read
Drug Development

Futura Medical Says Trial Results For Erectile Dysfunction Gel ‘Encouraging’

November 21, 2005
·
1 min read
Drug Development

Ascenta Therapeutics Inc. AT-101 Clinical Trial Data Presented At The AACR-NCI-EORTC International Conference On Molecular Targets And Cancer Therapeutics In Philadelphia, Pennsylvania

November 21, 2005
·
1 min read
Business

The U. S. FDA To Use IMMD’s KeyMolnet By integration With FDA’s ArrayTrack System For Reviewing Pharmacogenomic Data

November 21, 2005
·
1 min read